Michael Mendelsohn

Board of Directors @Foghorn Therapeutics Inc

Boston, MA, US

EMAILS

[email protected]

MOBILE NUMBERS

+91 *********19

Reveal Contact Details

Signup · Get unlimited contacts

WORK HISTORY

Jun 2016 — Present

Board of Directors @Foghorn Therapeutics Inc

View department →

Boston, MA, US

EDUCATION

1973 — 1977

Amherst College

B.A., Chemistry and English

1978 — 1982

Harvard Medical School

M.D., Medicine

SKILLS

Drug DevelopmentCancerLifesciencesMedicineInformaticsAcademic Medical CentersBiomarkersHuman PhysiologyLife SciencesInternal MedicineSenior Executive LeadershipPharmacologyClinical ResearchExecutive ManagementEarly DevelopmentClinical TrialsBiotechnologyDrug DesignMedical EducationAcademic MedicineCardiologyMolecular & Cellular BiologyMolecular PharmacologyCardiovascular PhysiologyImmunologyPharmaceutical IndustryHypertensionDrug DiscoveryClinical DevelopmentNeuroscience

ABOUT MICHAEL MENDELSOHN

Physician-scientist and healthcare executive (cardiovascular and internal medicine, basic and clinical sciences, biotechnology). Currently, Founder and Chairman, Cardurion Pharmaceuticals. From 20••••13, served as SVP and Global Franchise Head, Cardiovascular Diseases, Merck & Co, with global responsibilities for cardiovascular scientific strategy, research & development and drug discovery, business development and customer engagement. Prior to Merck, 25+ years as an academic cardiovascular physician-scientist at Tufts Medical Center and the Brigham and Women\'s Hospital, Boston.Therapeutic and scientific expertise: Cardiovascular Medicine; Internal Medicine; Molecular and Cellular Cardiovascular Biology. Business focus areas: Executive Management and Leadership, Drug Discovery and Development, Business Development and Strategy.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.